Vertebral Osteosynthesis in Degenerative Lumbar Stenosis With Spondylolisthesis (CLEOS)

March 15, 2015 updated by: University Hospital, Toulouse

Vertebral Osteosynthesis in Degenerative Lumbar Stenosis With Spondylolisthesis - CLEOS Study

Study to evaluate the superiority of the osteosynthesis associated with a decompressive surgery in comparison with a simple decompressive surgery in the treatment of lumbar degenerative stenosis with spondylolisthesis

Study Overview

Status

Terminated

Conditions

Detailed Description

Randomized, comparative study on 152 patients with degenerative spondylolisthesis L4-L5 confirmed by radiography with radicular pain for whom the antalgic and anti-inflammatory treatment are not efficient for at least 3 months.

Patients randomized in 2 parallel groups (each group with 76 patients)

  • one group with decompressive surgery + osteosynthesis
  • one group with decompressive surgery Study duration : 18 months, including a selection visit, an inclusion with the surgical intervention, 3, 12, 18 months' follow up visits and a follow up call at 6 months.

Study Type

Interventional

Enrollment (Actual)

11

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Besançon, France, 25030
        • University Hospital of Besançon - Neurosurgey department
      • Caen, France, 14033
        • University Hospital of Caen - Neurosurgery department
      • Clermont Ferrand, France, 63003
        • University Hospital of Clermont Ferrand
      • Montpellier, France, 34094
        • Clinique Rech - Neurosurgery centre
      • Nice, France, 06002
        • University Hospital of Nice - Neurosurgery department
      • Saint-Etienne, France, 42055
        • University Hospital of Saint-Etienne - Neurosurgery department
      • Strasbourg, France, 67098
        • University Hospital of Strasbourg
      • Toulouse, France, 31059
        • Toulouse University Hospital - Purpan - Neurosurgery department
      • Toulouse, France, 31059
        • Toulouse University Hospital - Rangueil- Neuro surgery department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with degenerative spondylolisthesis L4-L5 confirmed by radiography with radicular pain for whom the antalgic and anti-inflammatory treatment are not efficient for at least 3 months;
  • Patients who agree to take part in the study and to sign an Informed Consent Form

Exclusion Criteria:

  • Contre-indications to surgery or to vertebral isolated fixation L4-L5
  • Previous lumbar surgery
  • Work accidents
  • Psychiatric troubles that may interfere with the clinical evaluation
  • Pregnant women or women who could be pregnant during the study
  • Patient under special supervision or trusteeship
  • Refusal to sign the Informed Consent Form
  • No Public Health Insurance cover

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1
osteosynthesis
Active Comparator: 2
Simple surgery
Surgery without device

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
To evaluate the superiority of the osteosynthesis associated with a decompressive surgery in comparison with a simple decompressive surgery in the treatment of lumbar degenerative stenosis with spondylisthesis
Time Frame: M3, M12, M18
M3, M12, M18

Secondary Outcome Measures

Outcome Measure
Time Frame
improvement of patients' Quality of Life (SF36)
Time Frame: M18
M18
radiologic stability of spondylolisthesis
Time Frame: M18
M18
safety of the used surgical procedures
Time Frame: M3, M12, M18
M3, M12, M18

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jacques Lagarrigue, Toulouse University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2005

Primary Completion (Actual)

December 1, 2007

Study Completion (Actual)

December 1, 2007

Study Registration Dates

First Submitted

November 10, 2005

First Submitted That Met QC Criteria

November 10, 2005

First Posted (Estimate)

November 11, 2005

Study Record Updates

Last Update Posted (Estimate)

March 17, 2015

Last Update Submitted That Met QC Criteria

March 15, 2015

Last Verified

March 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • 0300201
  • PHRC0300201 (Other Grant/Funding Number: French Ministry of Health)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spondylolisthesis

Clinical Trials on Osteosynthesis

3
Subscribe